Enanta Pharmaceuticals, Inc. (ENTA): Price and Financial Metrics

ENTA POWR Grades

• Value is the dimension where ENTA ranks best; there it ranks ahead of 70.5% of US stocks.
• ENTA's strongest trending metric is Growth; it's been moving down over the last 179 days.
• ENTA's current lowest rank is in the Growth metric (where it is better than 10.93% of US stocks).

ENTA Stock Summary

• Of note is the ratio of Enanta Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; merely 6.07% of US stocks have a lower such ratio.
• ENTA's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 8.2% of US stocks.
• With a year-over-year growth in debt of 122.86%, Enanta Pharmaceuticals Inc's debt growth rate surpasses 91.52% of about US stocks.
• If you're looking for stocks that are quantitatively similar to Enanta Pharmaceuticals Inc, a group of peers worth examining would be RVMD, PTGX, SYRS, INO, and ALPN.
• Visit ENTA's SEC page to see the company's official filings. To visit the company's web site, go to www.enanta.com.

ENTA Valuation Summary

• In comparison to the median Healthcare stock, ENTA's price/sales ratio is 213.16% higher, now standing at 11.9.
• Over the past 103 months, ENTA's price/sales ratio has gone up 7.7.
• Over the past 103 months, ENTA's EV/EBIT ratio has gone down 18.3.

Below are key valuation metrics over time for ENTA.

ENTA Growth Metrics

Its 3 year price growth rate is now at 258.81%.
• Its year over year cash and equivalents growth rate is now at 3.72%.
• Its year over year revenue growth rate is now at -46.46%.

ENTA's revenue has moved down $141,005,000 over the prior 34 months.

The table below shows ENTA's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	92.979	-68.377	-100.783
2021-09-30	97.074	-69.996	-78.996
2021-06-30	97.13	-64.436	-83.738
2021-03-31	94.159	-39.418	-73.979
2020-12-31	101.646	-20.165	-57.939
2020-09-30	122.473	7.088	-36.168

ENTA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ENTA has a Quality Grade of C, ranking ahead of 57.4% of graded US stocks.
• ENTA's asset turnover comes in at 0.206 -- ranking 196th of 682 Pharmaceutical Products stocks.
• GILD, ALT, and RDUS are the stocks whose asset turnover ratios are most correlated with ENTA.

The table below shows ENTA's key quality metrics over time.